Lung Cancer


Phase II Study of Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations in EGFR

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

ECOG-ACRIN Cancer Research Group